WebThe company has set a record date of the rights issue on Announced Soon. The company will offer 24,67,16,400 Shares through this rights issue and through this issue and the company will collect ₹49.34 Crores. and the company Earum Pharmaceuticals Rights Issue Price of this issue has been announced at ₹2 per share as per the face value of ₹2. WebApr 10, 2024 · Shares of Deep Industries will turn ex-split while those of Earum Pharmaceuticals will go ex-rights today. The board of EID Parry (India), meanwhile, would consider a proposal of paying interim ...
Earum Pharmaceuticals Ltd Share Price, Stock Price Live NSE, BSE …
WebJul 15, 2024 · Earum Pharmace shares closed at 3.89 on July 14, 2024 (BSE) and has given -62.31% returns over the last 6 months and -43.87% over the last 12 months. Earum Pharmaceuticals Standalone Quarterly Results WebEarum Pharmaceuticals - Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Financial Year Ended On 31St March, 2024. fluxrequired openfoam
Earum Pharmaceuticals Ltd - Company Profile and News
WebOct 28, 2024 · About Quoin Pharmaceuticals, Ltd. Founded in 2024 as Quoin Pharmaceuticals Inc. by Michael Myers Ph.D. and Denise Carter, Quoin is an emerging … WebJun 15, 2024 · Earum Pharmaceuticals BSE SME IPO review (Avoid) EPL is engaged in pharma products trading activities only and has now own manufacturing unit. The issue is fully priced based on its recent financial performance. Currently, the pharma sector is being ignored by investors. Pharma trading is a high volume – low margin business with high … WebEarum Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is primarily engaged in marketing, trading and distribution of range of pharmaceutical formulation products, such as antibiotic drugs, antimalarial drugs, anti-allergic and anti-cold drugs, analgesic/anti-pyretic and anti-inflammatory drugs, … fluxrepair berlin